Institution · Xendo (Netherlands)
Most cited papers from Xendo (Netherlands)
What are the most cited papers from Xendo (Netherlands)?
The most cited paper from Xendo (Netherlands) is "LC-MS-MS experiences with internal standards" (Jaap Wieling, 2002), with 154 citations. Next come "Future directions for in‐situ product removal (ISPR)" (148) and "Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)" (118).
Showing 28 of 28 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | LC-MS-MS experiences with internal standards Jaap Wieling · Chromatographia | 2002 | 154 |
| 2 | Future directions for in‐situ product removal (ISPR) John M. Woodley, Marc A. T. Bisschops, Adrie J. J. Straathof et al. · Journal of Chemical Technology & Biotechnology | 25 Sep 2007 | 148 |
| 3 | Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) Walter JFM van der Velden, Thijs MP van Iersel, Nicole M. A. Blijlevens et al. · BMC Medicine | 8 Sep 2009 | 118 |
| 4 | Phase Behavior of an Intact Monoclonal Antibody Tangir Ahamed, Beatriz N.A. Esteban, Marcel Ottens et al. · Biophysical Journal | 20 Apr 2007 | 85 |
| 5 | The Influence of Remaining Live BCG Organisms in Vaccinated Mice on the Maintenance of Immunity to Tuberculosis Anja Weinreich Olsen, Lea Brandt, Else Marie Agger et al. · Scandinavian Journal of Immunology | 20 Aug 2004 | 73 |
| 6 | Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects Pierre A. M. Peeters, Michiel W. van den Heuvel, Emiel van Heumen et al. · Clinical Drug Investigation | Dec 2010 | 64 |
| 7 | Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers R.E. Aarnoutse, Jan Kleinnijenhuis, Peter J. Koopmans et al. · Clinical Pharmacology & Therapeutics | Dec 2005 | 60 |
| 8 | Pharmacokinetic Evaluation of Three Different Intramuscular Doses of Nandrolone Decanoate: Analysis of Serum and Urine Samples in Healthy Men Wilma M. Bagchus, Jean M. W. Smeets, Herman A. M. Verheul et al. · The Journal of Clinical Endocrinology & Metabolism | May 2005 | 46 |
| 9 | Absence of Excretion of the Active Moiety of Bisacodyl and Sodium Picosulfate into Human Breast Milk: an Open-label Parallel-group, Multiple-dose Study in Healthy Lactating Women Christian Friedrich, Erika Richter, Dirk Trommeshauser et al. · Drug Metabolism and Pharmacokinetics | 2011 | 31 |
| 10 | Surface crystallisation of yttrium aluminum garnet from a silicate glass Ashkan Keshavarzi, Wolfgang Wisniewski, René de Kloe et al. · CrystEngComm | 2013 | 30 |
| 11 | An international technology platform for influenza vaccines Jan T. Hendriks, Marit Holleman, Otto de Boer et al. · Vaccine | 25 Jun 2011 | 29 |
| 12 | Immunogenicity Assessment of Recombinant Human C1-Inhibitor C. Erik Hack, Maurice L. M. Mannesse, Aartie Baboeram et al. · BioDrugs | Oct 2012 | 19 |
| 13 | Integration of Pharmacogenetics and Pharmacogenomics in Drug Development: Implications for Regulatory and Medical Decision Making in Pediatric Diseases Chiara Piana, Linda C. Surh, Sabine Fürst‐Recktenwald et al. · The Journal of Clinical Pharmacology | 14 May 2011 | 18 |
| 14 | Mephenytoin as a probe for CYP2C19 phenotyping:effect of sample storage, intra‐individual reproducibility and occurrence of adverse events Wim J. Tamminga, Johan Wemer, Berend Oosterhuis et al. · British Journal of Clinical Pharmacology | May 2001 | 17 |
| 15 | Evaluation of analytical and clinical performance of a dual-probe phenotyping method for CYP2D6 polymorphism and CYP3A4 activity screening. Jaap Wieling, Wim J. Tamminga, Elly Sakiman et al. · Therapeutic Drug Monitoring | Aug 2000 | 16 |
| 16 | The effect of the CYP2C19*2 heterozygote genotype on the pharmacokinetics of nelfinavir David Marinus Burger, H. R. Schwietert, E. P. H. Colbers et al. · British Journal of Clinical Pharmacology | 20 Feb 2006 | 14 |
| 17 | An Empirical Study on the Impact of Bioanalytical Method Variability on Estimation of PK Parameters Jaap Wieling, Cornelis Tump · Chromatographia | 30 Mar 2004 | 8 |
| 18 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers. Khalid Abd‐Elaziz, Pieter Willem Kamphuisen, Christophe Lyssens et al. · Blood | 20 Nov 2009 | 7 |
| 19 | Innovation of Expanded‐Bed Adsorption by Integrating Simulated Moving‐Bed Technology Trinath Pathapati, Dennis N. Rütze, Pieter de Wit et al. · Chemical Engineering & Technology | 22 Sep 2018 | 5 |
| 20 | NXY‐059 Does Not Affect Bleeding Time in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled, 3‐Period Crossover Phase I Study Dag Nilsson, Johan Wemer, Yi‐Fang Cheng et al. · The Journal of Clinical Pharmacology | 23 Jan 2007 | 5 |
| 21 | Effects of Tibolone on Sulfatase Pathway of Estrogens Metabolism and on Growth of MCF-7 Human Breast Tumors Implanted in Ovariectomized Nude Mice Joëlle Desreux, Helenius J. Kloosterboer, Agnès Noël et al. · Gynecologic and Obstetric Investigation | 7 Aug 2006 | 4 |
| 22 | Expanded Bed Adsorption of γ‐Aminobutyric Acid from E. coli broth by CS16GC and IRC747 Resins Trinath Pathapati, Dennis N. Rütze, Piet den Boer et al. · Chemical Engineering & Technology | 25 Sep 2018 | 3 |
| 23 | Active Renal Secretion of NXY‐059, a Novel Neuroprotectant, Is Mediated via an Organic Acid Transporter Yi‐Fang Cheng, Stig Strid, Olof Borgå et al. · The Journal of Clinical Pharmacology | 21 Jun 2007 | 3 |
| 24 | Direct, On-Site, On-Cartridge Toxicokinetic Sampling Prior to On-Line SPE: A Feasibility Study Cornelis Tump, Martijn J. Hilhorst, Jan Albert Ooms et al. · Chromatographia | May 2004 | 3 |
| 25 | Hybridizing Simulated Moving Bed and Electrodialysis: Product Purification and Eluent Regeneration Kiara Kochendoerfer, Pedro Sá Gomes, Dennis N. Rütze et al. · Chemical Engineering & Technology | 25 Sep 2018 | 2 |
| 26 | NXY‐059 Does Not Significantly Interact With Furosemide in Healthy Volunteers Stig Strid, Dag Nilsson, Olof Borgå et al. · The Journal of Clinical Pharmacology | 13 Nov 2006 | 2 |
| 27 | Disposable Bioreactors Nico M. G. Oosterhuis, T. Hudson, A. D’Avino et al. · Elsevier eBooks | Nov 2016 | 1 |
| 28 | PRODIAS: Purification of a Fermentation Broth by Adsorption/Ion Exchange Kiara Kochendoerfer, G. Iffland, Pedro Sá Gomes et al. · Chemie Ingenieur Technik | 29 Aug 2016 | 1 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.